SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 323 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $340,000 | +58.1% | 2,418 | +79.9% | 0.01% | +50.0% |
| Q2 2020 | $215,000 | +5.9% | 1,344 | -35.3% | 0.00% | -20.0% |
| Q1 2020 | $203,000 | -53.2% | 2,076 | -38.2% | 0.01% | -50.0% |
| Q4 2019 | $434,000 | +61.9% | 3,360 | -5.6% | 0.01% | +42.9% |
| Q3 2019 | $268,000 | -43.2% | 3,559 | +14.5% | 0.01% | -46.2% |
| Q2 2019 | $472,000 | +34.1% | 3,107 | +5.2% | 0.01% | +30.0% |
| Q1 2019 | $352,000 | -24.6% | 2,954 | -30.9% | 0.01% | -33.3% |
| Q4 2018 | $467,000 | -35.9% | 4,275 | -5.3% | 0.02% | -28.6% |
| Q3 2018 | $729,000 | +24.4% | 4,513 | +1.7% | 0.02% | +16.7% |
| Q2 2018 | $586,000 | +99.3% | 4,437 | +12.0% | 0.02% | +100.0% |
| Q1 2018 | $294,000 | +19.0% | 3,963 | -10.6% | 0.01% | +12.5% |
| Q4 2017 | $247,000 | – | 4,434 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |